{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:39:50Z","timestamp":1792143590911,"version":"4.4.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pnpbp.2026.111738","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:13:10Z","timestamp":1778339590000},"page":"111738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Genetic and epigenetic predictors of antidepressant response"],"prefix":"10.1016","volume":"147","author":[{"given":"Stanley","family":"Lyndon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pnpbp.2026.111738_bb0005","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11725","article-title":"Direct and indirect cost burden and change of employment status in treatment-resistant depression: a matched-cohort study using a US commercial claims database","volume":"79","author":"Amos","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111738_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpsychires.2016.07.009","article-title":"Predisposition to treatment response in major depressive episode: a peripheral blood gene coexpression network analysis","volume":"81","author":"Belzeaux","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2026.111738_bb0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jad.2018.04.016","article-title":"Treatment-resistant depression and suicidality","volume":"235","author":"Bergfeld","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111738_bb0020","article-title":"The international SSRI pharmacogenomics consortium (ISPC): a genome-wide association study of antidepressant treatment response. Transl","volume":"5","author":"Biernacka","year":"2015","journal-title":"Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111738_bb0025","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng1479","article-title":"Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment","volume":"36","author":"Binder","year":"2004","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/a-1288-1061","article-title":"Review and consensus on pharmacogenomic testing in psychiatry","volume":"54","author":"Bousman","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cpt.2903","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants","volume":"114","author":"Bousman","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111738_bb0040","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/cts.13347","article-title":"Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population","volume":"15","author":"Br\u00e5ten","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.pnpbp.2026.111738_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114824","article-title":"Current and future directions of drug delivery for the treatment of mental illnesses","volume":"197","author":"Brewster","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111738_bb0050","first-page":"1303","article-title":"Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials","volume":"112","author":"Brown","year":"2022","journal-title":"Controlled Clinical Trials. Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111738_bb0055","first-page":"130","article-title":"Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian genetics of depression study","volume":"22","author":"Campos","year":"2022","journal-title":"Pharm. J."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111738_bb0060","article-title":"MicroRNAs as diagnostic biomarkers and predictors of antidepressant response in major depressive disorder: a systematic review","volume":"16","author":"Carneiro","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111738_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/npp.2012.191","article-title":"Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline \u2018predictors\u2019 and longitudinal \u2018targets\u2019","volume":"38","author":"Cattaneo","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12888-023-04791-z","article-title":"Early antidepressant treatment response prediction in major depression using clinical and TPH2 DNA methylation features based on machine learning approaches","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111738_bb0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41386-019-0316-9","article-title":"Transcriptomic predictors of inflammation-induced depressed mood","volume":"44","author":"Cho","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111738_bb0080","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1017\/S146114571400039X","article-title":"Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response","volume":"17","author":"Domschke","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111738_bb0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41573-021-00368-1","article-title":"Immune targets for therapeutic development in depression: towards precision medicine","volume":"21","author":"Drevets","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41398-022-02032-7","article-title":"Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial","volume":"12","author":"Engelmann","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111738_bb0095","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.euroneuro.2018.05.009","article-title":"Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies","volume":"28","author":"Fabbri","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41398-020-0738-5","article-title":"A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping","volume":"10","author":"Fabbri","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111738_bb0105","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/s41380-021-01062-9","article-title":"Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts","volume":"26","author":"Fabbri","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"19","key":"10.1016\/j.pnpbp.2026.111738_bb0110","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.3390\/ijms251910373","article-title":"Are BDNF and stress levels related to antidepressant response?","volume":"25","author":"Flores-Ramos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.pnpbp.2026.111738_bb0115","doi-asserted-by":"crossref","first-page":"12199","DOI":"10.3390\/ijms241512199","article-title":"Changes in multiple microRNA levels with antidepressant treatment are associated with remission and interact with key pathways: a comprehensive microRNA analysis","volume":"24","author":"Funatsuki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111738_bb0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1176\/appi.ajp.2009.08081167","article-title":"Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder","volume":"167","author":"Garriock","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111738_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2826","article-title":"Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: an explorative psychopharmacological study with naturalistic design","volume":"37","author":"Geers","year":"2022","journal-title":"Hum. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111738_bb0130","first-page":"13","article-title":"The interplay between SLC6A4 and HTR1A genetic variants that may lead to antidepressant failure","volume":"25","author":"Hanna","year":"2025","journal-title":"Pharm. J."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cpt.597","article-title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update","volume":"102","author":"Hicks","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111738_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jpsychires.2009.08.015","article-title":"Altered gene expression of histone deacetylases in mood disorder patients","volume":"44","author":"Hobara","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111738_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/0269881113512041","article-title":"Genetic differences in cytochrome P450 enzymes and antidepressant treatment response","volume":"28","author":"Hodgson","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111738_bb0150","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pnpbp.2006.12.014","article-title":"Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression","volume":"31","author":"Iga","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41398-019-0589-0","article-title":"Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants","volume":"9","author":"Ju","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111738_bb0160","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1176\/appi.ajp.20230247","article-title":"Genome-wide association study of treatment-resistant depression: shared biology with metabolic traits","volume":"181","author":"Kang","year":"2024","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1586\/ern.10.186","article-title":"Pharmacogenetics of antidepressant response","volume":"11","author":"Keers","year":"2011","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.pnpbp.2026.111738_bb0170","article-title":"Genome-wide meta-analyses of non-response to antidepressants identify novel loci and potential drugs","author":"Koch","year":"2024","journal-title":"Preprint. Res. Sq."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41398-020-01035-6","article-title":"23andMe research team. Genome-wide association studies of antidepressant class response and treatment-resistant depression","volume":"10","author":"Li","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41398-024-02981-1","article-title":"Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis","volume":"14","author":"Li","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111738_bb0185","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jad.2014.06.012","article-title":"Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis","volume":"168","author":"Lin","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111738_bb0190","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nm.3582","article-title":"miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment","volume":"20","author":"Lopez","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2026.111738_bb0195","doi-asserted-by":"crossref","DOI":"10.1177\/07067437251329073","article-title":"Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des r\u00e9sultats du traitement antid\u00e9presseur \u00e0 l\u2019aide des scores de risque polyg\u00e9niques\u202f: Rapport sur l\u2019\u00e9tude CAN-BIND-1","author":"Magarbeh","year":"2025","journal-title":"Can. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111738_bb0200","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41431-021-00996-6","article-title":"A summary-statistics-based approach to examine the role of serotonin transporter promoter tandem repeat polymorphism in psychiatric phenotypes","volume":"30","author":"Majumdar","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2026.111738_bb0205","article-title":"Role of FKBP5 and its genetic mutations in stress-induced psychiatric disorders: an opportunity for drug discovery","volume":"14","author":"Malekpour","year":"2023","journal-title":"Front. Psychol."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111738_bb0210","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/503820","article-title":"Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment","volume":"78","author":"McMahon","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111738_bb0215","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1176\/appi.ajp.2007.06111790","article-title":"Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort","volume":"164","author":"Paddock","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111738_bb0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bpsgos.2021.07.008","article-title":"Identifying the common genetic basis of antidepressant response","volume":"2","author":"Pain","year":"2022","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111738_bb0225","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.3390\/ijms22105398","article-title":"Epigenetic targeting of histone deacetylases in diagnostics and treatment of depression","volume":"22","author":"Park","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0230","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41398-020-01067-y","article-title":"Corticotropin releasing hormone receptor CRHR1 gene is associated with tianeptine antidepressant response in a large sample of outpatients from real-life settings","volume":"10","author":"Ramoz","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111738_bb0235","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/npp.2013.319","article-title":"Fluoxetine epigenetically alters the CaMKII\u03b1 promoter in nucleus accumbens to regulate \u0394FosB binding and antidepressant effects","volume":"39","author":"Robison","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111738_bb0240","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111738_bb0245","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyae045","article-title":"Epigenome-wide DNA methylation in unipolar depression: predictive biomarker of antidepressant treatment response?","volume":"27","author":"Schiele","year":"2024","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111738_bb0250","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001926","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients","volume":"12","author":"Serretti","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0255","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41398-024-02998-6","article-title":"Pharmacogenomic scores in psychiatry: systematic review of current evidence","volume":"14","author":"Sharew","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111738_bb0260","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.mp.4000425","article-title":"Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine","volume":"3","author":"Smeraldi","year":"1998","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111738_bb0265","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/jpm11121334","article-title":"Serotonin transporter genetic variation and antidepressant response and tolerability: a systematic review and Meta-analysis","volume":"11","author":"Stein","year":"2021","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0270","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1176\/appi.ajp.2017.17030283","article-title":"Psychiatric genomics: an update and an agenda","volume":"175","author":"Sullivan","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0275","first-page":"49","article-title":"The catechol-O-methyltransferase Val108\/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression","volume":"5","author":"Szegedi","year":"2005","journal-title":"Pharm. J."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111738_bb0280","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biopsych.2012.10.030","article-title":"Contribution of common genetic variants to antidepressant response","volume":"73","author":"Tansey","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111738_bb0285","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopsych.2010.04.034","article-title":"Antidepressant response and the serotonin transporter gene-linked polymorphic region","volume":"68","author":"Taylor","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0290","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111738_bb0295","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nn1659","article-title":"Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action","volume":"9","author":"Tsankova","year":"2006","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111738_bb0300","first-page":"225","article-title":"Genetic predictors of response to antidepressants in the GENDEP project","volume":"9","author":"Uher","year":"2009","journal-title":"Pharm. J."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111738_bb0305","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1176\/appi.ajp.2009.09070932","article-title":"Genome-wide pharmacogenetics of antidepressant response in the GENDEP project","volume":"167","author":"Uher","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111738_bb0310","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-pharmtox-010611-134540","article-title":"Epigenetic mechanisms of depression and antidepressant action","volume":"53","author":"Vialou","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0315","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41398-021-01536-y","article-title":"Genome-wide DNA methylation and gene expression analyses in monozygotic twins identify potential biomarkers of depression","volume":"11","author":"Wang","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111738_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0123-0","article-title":"Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis","volume":"50","author":"Woo","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111738_bb0325","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.5498\/wjp.v14.i10.1573","article-title":"Association between 5-HTR1A gene C-1019G polymorphism and antidepressant response in patients with major depressive disorder: a meta-analysis","volume":"14","author":"Wu","year":"2024","journal-title":"World J Psychiatry."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111738_bb0330","doi-asserted-by":"crossref","first-page":"39955","DOI":"10.31083\/AP39955","article-title":"BDNF gene polymorphism and antidepressant response in Han Chinese patients with first-episode late-life depression","volume":"26","author":"Wu","year":"2025","journal-title":"Alpha Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0335","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41398-023-02602-3","article-title":"Polygenic risk scores of lithium response and treatment resistance in major depressive disorder","volume":"13","author":"Xiong","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111738_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-025-03084-z","article-title":"Genome-wide association meta-analysis and rare copy number variant analysis of treatment-resistant depression","author":"Xiong","year":"2025","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111738_bb0345","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw070","article-title":"TPH-2 polymorphisms interact with early life stress to influence response to treatment with antidepressant drugs","volume":"19","author":"Xu","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111738_bb0350","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/appy.12148","article-title":"Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis","volume":"6","author":"Yan","year":"2014","journal-title":"Asia Pac. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111738_bb0355","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/sj.npp.1300172","article-title":"Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response","volume":"28","author":"Yu","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111738_bb0360","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41392-023-01519-z","article-title":"Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential","volume":"8","author":"Yuan","year":"2023","journal-title":"Sig. Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111738_bb0365","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12888-024-05717-z","article-title":"The association of FKBP5 gene polymorphism with genetic susceptibility to depression and response to antidepressant treatment- a systematic review","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111738_bb0370","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jpsychires.2023.06.017","article-title":"The emerging role of long noncoding RNA in depression and its implications in diagnostics and therapeutic responses","volume":"164","author":"Zhong","year":"2023","journal-title":"J. Psychiatr. Res."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626001351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626001351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:28:23Z","timestamp":1785205703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626001351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":74,"alternative-id":["S0278584626001351"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111738","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and epigenetic predictors of antidepressant response","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111738"}}